<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Worby CJ</submitter><funding>Doris Duke Charitable Foundation</funding><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>NIGMS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><pagination>630-639</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9136705</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(5)</volume><pubmed_abstract>Recurrent urinary tract infections (rUTIs) are a major health burden worldwide, with history of infection being a significant risk factor. While the gut is a known reservoir for uropathogenic bacteria, the role of the microbiota in rUTI remains unclear. We conducted a year-long study of women with (n = 15) and without (n = 16) history of rUTI, from whom we collected urine, blood and monthly faecal samples for metagenomic and transcriptomic interrogation. During the study 24 UTIs were reported, with additional samples collected during and after infection. The gut microbiome of individuals with a history of rUTI was significantly depleted in microbial richness and butyrate-producing bacteria compared with controls, reminiscent of other inflammatory conditions. However, Escherichia coli gut and bladder populations were comparable between cohorts in both relative abundance and phylogroup. Transcriptional analysis of peripheral blood mononuclear cells revealed expression profiles indicative of differential systemic immunity between cohorts. Altogether, these results suggest that rUTI susceptibility is in part mediated through the gut-bladder axis, comprising gut dysbiosis and differential immune response to bacterial bladder colonization, manifesting in symptoms.</pubmed_abstract><journal>Nature microbiology</journal><pubmed_title>Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.</pubmed_title><pmcid>PMC9136705</pmcid><funding_grant_id>U01AI095542</funding_grant_id><funding_grant_id>U19AI110818</funding_grant_id><funding_grant_id>R01 DK121822</funding_grant_id><funding_grant_id>T32 GM007067</funding_grant_id><funding_grant_id>R01 AI165915</funding_grant_id><funding_grant_id>2019083</funding_grant_id><funding_grant_id>U01 AI095542</funding_grant_id><funding_grant_id>T32 GM139774</funding_grant_id><funding_grant_id>R37 AI048689</funding_grant_id><funding_grant_id>U19 AI110818</funding_grant_id><pubmed_authors>Bronson RA</pubmed_authors><pubmed_authors>Schreiber HL</pubmed_authors><pubmed_authors>Azimzadeh PN</pubmed_authors><pubmed_authors>Chapman SB</pubmed_authors><pubmed_authors>Manson AL</pubmed_authors><pubmed_authors>Klim A</pubmed_authors><pubmed_authors>Dodson KW</pubmed_authors><pubmed_authors>Obernuefemann CLP</pubmed_authors><pubmed_authors>Munoz VL</pubmed_authors><pubmed_authors>Earl AM</pubmed_authors><pubmed_authors>Straub TJ</pubmed_authors><pubmed_authors>Lai HH</pubmed_authors><pubmed_authors>Walker BJ</pubmed_authors><pubmed_authors>Paharik AE</pubmed_authors><pubmed_authors>van Dijk LR</pubmed_authors><pubmed_authors>Kau AL</pubmed_authors><pubmed_authors>Bergeron K</pubmed_authors><pubmed_authors>Worby CJ</pubmed_authors><pubmed_authors>Chou WC</pubmed_authors><pubmed_authors>Hannan TJ</pubmed_authors><pubmed_authors>Olson BS</pubmed_authors><pubmed_authors>Desjardins CA</pubmed_authors><pubmed_authors>Hooton TM</pubmed_authors><pubmed_authors>Hultgren SJ</pubmed_authors><pubmed_authors>Pinkner JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.</name><description>Recurrent urinary tract infections (rUTIs) are a major health burden worldwide, with history of infection being a significant risk factor. While the gut is a known reservoir for uropathogenic bacteria, the role of the microbiota in rUTI remains unclear. We conducted a year-long study of women with (n = 15) and without (n = 16) history of rUTI, from whom we collected urine, blood and monthly faecal samples for metagenomic and transcriptomic interrogation. During the study 24 UTIs were reported, with additional samples collected during and after infection. The gut microbiome of individuals with a history of rUTI was significantly depleted in microbial richness and butyrate-producing bacteria compared with controls, reminiscent of other inflammatory conditions. However, Escherichia coli gut and bladder populations were comparable between cohorts in both relative abundance and phylogroup. Transcriptional analysis of peripheral blood mononuclear cells revealed expression profiles indicative of differential systemic immunity between cohorts. Altogether, these results suggest that rUTI susceptibility is in part mediated through the gut-bladder axis, comprising gut dysbiosis and differential immune response to bacterial bladder colonization, manifesting in symptoms.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-04-08T10:05:38.041Z</modification><creation>2025-04-19T22:48:21.606Z</creation></dates><accession>S-EPMC9136705</accession><cross_references><pubmed>35505248</pubmed><doi>10.1038/s41564-022-01107-x</doi></cross_references></HashMap>